| User's Publication |
|
19673
Paik PK, Fan PD, Qeriqi B, Namakydoust A, Daly B, Ahn L, Kim R, Plodkowski A, Ni A, Chang J, Fanaroff R, Ladanyi M, de Stanchina E, Rudin CM.
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
J Thorac Oncol
2023
18(4):516-526
PubMed ID: 36240971
DOI: 10.1016/j.jtho.2022.09.225
|
|
19725
Kotani N, Araki T, Miyagawa-Yamaguchi A, Amimoto T, Nakano M, Honke K.
Proximity Labeling and Proteomics: Get to Know Neighbors
Methods Enzymol
2023
131-162
PubMed ID: 36682860
DOI: 10.1016/bs.mie.2022.07.031
|
|
17825
Akhela Umapathi, Harishkumar Madhyastha, P.N. Navya, Mandeep Singh, Radha Madhyastha, Hemant Kumar Daima
Surface chemistry driven selective anticancer potential of functional silver nanoparticles toward lung cancer cells
Colloids and Surfaces A: Physicochemical and Engineering Aspects
2022
652:129809
DOI: 10.1016/j.colsurfa.2022.129809
|
|
16830
Sumiya R, Terayama M, Hagiwara T, Nakata K, Sekihara K, Nagasaka S, Miyazaki H, Igari T, Yamada K, Kawamura YI.
Loss of GSTO2 contributes to cell growth and mitochondria function via the p38 signaling in lung squamous cell carcinoma
Cancer Sci
2022
113(1):195-204
PubMed ID: 34726807
DOI: 10.1111/cas.15189
|
|
13332
Hase H, Aoki M, Matsumoto K, Nakai S, Nagata T, Takeda A, Ueda K, Minami K, Kitae K, Jingushi K, Ueda Y, Yamamoto M, Furukawa T, Sato M, Tsujikawa K.
Cancer type‑SLCO1B3 promotes epithelial‑mesenchymal transition resulting in the tumour progression of non‑small cell lung cancer.
Oncol Rep
2021
PubMed ID: 33155667
DOI: 10.3892/or.2020.7839
|
|
20043
Yuan G, Flores NM, Hausmann S, Lofgren SM, Kharchenko V, Angulo-Ibanez M, Sengupta D, Lu X, Czaban I, Azhibek D, Vicent S, Fischle W, Jaremko M, Fang B, Wistuba II, Chua KF, Roth JA, Minna JD, Shao NY, Jaremko Ł, Mazur PK, Gozani O.
Elevated NSD3 histone methylation activity drives squamous cell lung cancer.
Nature
2021
590(7846):504-508
PubMed ID: 33536620
DOI: 10.1038/s41586-020-03170-y
|
|
20104
Abe K, Kanehira M, Ohkouchi S, Kumata S, Suzuki Y, Oishi H, Noda M, Sakurada A, Miyauchi E, Fujiwara T, Harigae H, Okada Y.
Targeting stanniocalcin-1-expressing tumor cells elicits efficient antitumor effects in a mouse model of human lung cancer.
Cancer Med
2021
PubMed ID: 33826244
DOI: 10.1002/cam4.3852
|
|
14789
Chang A, Liu L, Ashby JM, Wu D, Chen Y, O'Neill SS, Huang S, Wang J, Wang G, Cheng D, Tan X, Petty WJ, Pasche BC, Xiang R, Zhang W, Sun P.
Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer
Cancer Res
2021
81(12):3358-3373
PubMed ID: 33853832
DOI: 10.1158/0008-5472.CAN-21-0688
|
|
16801
Minegishi K, Dobashi Y, Tsubochi H, Hagiwara K, Ishibashi Y, Nomura S, Nakamura R, Ohmoto Y, Endo S.
TFF-1 Functions to Suppress Multiple Phenotypes Associated with Lung Cancer Progression
Onco Targets Ther
2021
14:4761-4777
PubMed ID: 34531663
DOI: 10.2147/OTT.S322697
|
|
13573
Hisako Kaneda et al
Bimolecule detection for Extracellular Vesicle Screening
bioRxiv
2020
September 27
DOI: 10.1101/2020.07.23.217018
|
|
13773
Saigusa D, Motoike IN, Saito S, Zorzi M, Aoki Y, Kitamura H, Suzuki M, Katsuoka F, Ishii H, Kinoshita K, Motohashi H, Yamamoto M.
Impacts of NRF2 activation in non-small-cell lung cancer cell lines on extracellular metabolites
Cancer Sci
2020
111(2):667-678
PubMed ID: 31828882
DOI: 10.1111/cas.14278
|
|
11422
Hori R, Yamaguchi K, Sato H, Watanabe M, Tsutsumi K, Iwamoto S, Abe M, Onodera H, Nakamura S, Nakai R.
The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Cancer Med
2019
PubMed ID: 30735010
DOI: 10.1002/cam4.1949
|
|
12335
Mochizuki M, Nakamura M, Sibuya R, Okazaki T, Abe J, Nakagawa T, Takahashi S, Yamazaki T, Imai T, Takano A, Ito H, Yokose T, Miyagi Y, Daigo Y, Sato I, Satoh K, Sugamura K, Yamaguchi K, Tamai K.
CD271 is a negative prognostic factor and essential for cell proliferation in lung squamous cell carcinoma
Lab Invest
2019
99(9):1349-1362
PubMed ID: 31019292
DOI: 10.1038/s41374-019-0246-5
|
|
14238
Ozono K, Ohishi Y, Onishi H, Nakamura K, Motoshita J, Kato M, Nakanishi R, Nakamura M, Oda Y.
Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma
Lab Invest
2017
97(11):1332-1342
PubMed ID: 28604655
DOI: 10.1038/labinvest.2017.45
|
|
9887
Ye X, Zhou Q, Matsumoto Y, Moriyama M, Kageyama S, Komatsu M, Satoh S, Tsuchida M, Saijo Y.
Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma.
Anticancer Res.
2016
36:6021-6029
PubMed ID: 27793929
DOI: 10.21873/anticanres.11191
|
|
15159
Honda S, Loher P, Shigematsu M, Palazzo JP, Suzuki R, Imoto I, Rigoutsos I, Kirino Y.
Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers
Proc Natl Acad Sci U S A
2015
112(29):E3816-25
PubMed ID: 26124144
DOI: 10.1073/pnas.1510077112
|
|
15909
Fang WT, Fan CC, Li SM, Jang TH, Lin HP, Shih NY, Chen CH, Wang TY, Huang SF, Lee AY, Liu YL, Tsai FY, Huang CT, Yang SJ, Yen LJ, Chuu CP, Chen CY, Hsiung CA, Chang JY, Wang LH, Chang IS, Jiang SS.
Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma
Int J Cancer
2014
135(4):809-19
PubMed ID: 24477565
DOI: 10.1002/ijc.28734
|
|
19029
Kanamori-Katayama M, Kaiho A, Ishizu Y, Okamura-Oho Y, Hino O, Abe M, Kishimoto T, Sekihara H, Nakamura Y, Suzuki H, Forrest AR, Hayashizaki Y.
LRRN4 and UPK3B are markers of primary mesothelial cells
PLoS One
2011
6(10):e25391
PubMed ID: 21984916
DOI: 10.1371/journal.pone.0025391
|
|
16553
Hayashi S, Kumai T, Matsuda Y, Aoki N, Sato K, Kimura S, Kitada M, Tateno M, Celis E, Kobayashi H.
Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
J Transl Med
2011
9:191
PubMed ID: 22053850
DOI: 10.1186/1479-5876-9-191
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
18311
Mitsuoka K, Miyoshi S, Kato Y, Murakami Y, Utsumi R, Kubo Y, Noda A, Nakamura Y, Nishimura S, Tsuji A.
Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporter
J Nucl Med
2008
49(4):615-22
PubMed ID: 18344442
DOI: 10.2967/jnumed.107.048231
|
|
16648
Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M.
The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients
Hum Immunol
2004
65(11):1377-88
PubMed ID: 15556688
DOI: 10.1016/j.humimm.2004.09.003
|
Back
Top
CELL BANK Website
